作者: Jan Stoehlmacher , David Jong-Han Park , Heinz-Josef Lenz
DOI:
关键词: Internal medicine 、 Increased risk 、 Nucleic Acid Probes 、 Treatment outcome 、 Cancer risk 、 Treatment response 、 Oncology 、 Chemotherapy 、 Pathology 、 Disease 、 Radiation therapy 、 Medicine
摘要: The invention provides compositions and methods for determining the increased risk recurrence of certain cancers likelihood successful treatment with one or both chemotherapy radiation therapy. comprising type genomic polymorphism present in a predetermined region gene interest isolated from subject patient. Also provided are nucleic acid probes kits patient's cancer response.